341 related articles for article (PubMed ID: 32529962)
21. Peripherally inserted central catheters have a protective role and the effect of fluctuation curve feature in the risk of bloodstream infection compared with central venous catheters: a propensity-adjusted analysis.
Lv Y; Huang X; Lan Y; Xia Q; Chen F; Wu J; Li W; Cao H; Xie C; Li L; Han H; Wang H; Xiang Q
BMC Infect Dis; 2022 Mar; 22(1):289. PubMed ID: 35346073
[TBL] [Abstract][Full Text] [Related]
22. Line days as a determinant of central line-associated bloodstream infections in pediatric patients with tunneled femoral peripherally inserted central catheters.
Koo KSH; Cooper AB; Monroe EJ; Reis J; Shivaram GM; Zerr DM
Pediatr Radiol; 2021 Jul; 51(8):1481-1486. PubMed ID: 33675377
[TBL] [Abstract][Full Text] [Related]
23. Central venous access devices for the delivery of systemic anticancer therapy (CAVA): a randomised controlled trial.
Moss JG; Wu O; Bodenham AR; Agarwal R; Menne TF; Jones BL; Heggie R; Hill S; Dixon-Hughes J; Soulis E; Germeni E; Dillon S; McCartney E;
Lancet; 2021 Jul; 398(10298):403-415. PubMed ID: 34297997
[TBL] [Abstract][Full Text] [Related]
24. Comparison of complications associated with peripherally inserted central catheters and Hickman™ catheters in patients with intestinal failure receiving home parenteral nutrition. Six-year follow up study.
Christensen LD; Holst M; Bech LF; Drustrup L; Nygaard L; Skallerup A; Rasmussen HH; Vinter-Jensen L
Clin Nutr; 2016 Aug; 35(4):912-7. PubMed ID: 26269383
[TBL] [Abstract][Full Text] [Related]
25. Comparison of peripherally inserted central venous catheters (PICC) versus subcutaneously implanted port-chamber catheters by complication and cost for patients receiving chemotherapy for non-haematological malignancies.
Patel GS; Jain K; Kumar R; Strickland AH; Pellegrini L; Slavotinek J; Eaton M; McLeay W; Price T; Ly M; Ullah S; Koczwara B; Kichenadasse G; Karapetis CS
Support Care Cancer; 2014 Jan; 22(1):121-8. PubMed ID: 24005884
[TBL] [Abstract][Full Text] [Related]
26. Peripherally inserted central catheters may lower the incidence of catheter-related blood stream infections in patients in surgical intensive care units.
Gunst M; Matsushima K; Vanek S; Gunst R; Shafi S; Frankel H
Surg Infect (Larchmt); 2011 Aug; 12(4):279-82. PubMed ID: 20629557
[TBL] [Abstract][Full Text] [Related]
27. Experience of Peripherally Inserted Central Venous Catheter in Patients with Hematologic Diseases.
Hashimoto Y; Fukuta T; Maruyama J; Omura H; Tanaka T
Intern Med; 2017; 56(4):389-393. PubMed ID: 28202859
[TBL] [Abstract][Full Text] [Related]
28. Cost-effectiveness Analysis of Peripherally Inserted Central Catheters Versus Central Venous Catheters for in-Hospital Parenteral Nutrition.
Comas M; Domingo L; Jansana A; Lafuente E; Civit A; García-Pérez L; Lasso de la Vega C; Cots F; Sala M; Castells X
J Patient Saf; 2022 Oct; 18(7):e1109-e1115. PubMed ID: 35587883
[TBL] [Abstract][Full Text] [Related]
29. Catheter-related complications in onco-hematologic children: A retrospective clinical study on 227 central venous access devices.
Annetta MG; Celentano D; Zumstein L; Attinà G; Ruggiero A; Conti G; Pittiruti M
J Vasc Access; 2024 Mar; 25(2):512-518. PubMed ID: 36113076
[TBL] [Abstract][Full Text] [Related]
30. Comparison of microbial colonization rates between central venous catheters and peripherally inserted central catheters.
Pitiriga V; Bakalis J; Theodoridou K; Dimitroulia E; Saroglou G; Tsakris A
Antimicrob Resist Infect Control; 2023 Aug; 12(1):74. PubMed ID: 37550791
[TBL] [Abstract][Full Text] [Related]
31. Peripherally inserted central catheter versus totally implanted venous port for delivering medium- to long-term chemotherapy: A cost-effectiveness analysis based on propensity score matching.
Wang K; Zhou Y; Huang N; Lu Z; Zhang X
J Vasc Access; 2022 May; 23(3):365-374. PubMed ID: 33579176
[TBL] [Abstract][Full Text] [Related]
32. Peripherally Inserted Central Venous Catheter for Pediatric and Young Adult Patients With Hematologic and Malignant Diseases.
Suzuki D; Kobayashi R; Sano H; Yanagi M; Hori D; Matsushima S; Nakano T; Kobayashi K
J Pediatr Hematol Oncol; 2020 Oct; 42(7):429-432. PubMed ID: 32102052
[TBL] [Abstract][Full Text] [Related]
33. Should you pick the PICC? Prolonged use of peripherally inserted central venous catheters in children with intestinal failure.
LaRusso K; Schaack G; Fung T; McGregor K; Long J; Dumas MP; Attari Z; Yousef Y; Girgis H; Raghunathan R; Sant'Anna A; Emil S
J Pediatr Surg; 2019 May; 54(5):999-1004. PubMed ID: 30795912
[TBL] [Abstract][Full Text] [Related]
34. Comparison of peripherally inserted central catheters and totally implanted venous access devices as chemotherapy delivery routes in oncology patients: A retrospective cohort study.
Yun WS; Yang SS
Sci Prog; 2021; 104(2):368504211011871. PubMed ID: 33950754
[TBL] [Abstract][Full Text] [Related]
35. Hemodialysis tunneled central venous catheters: five-year outcome analysis.
Mandolfo S; Acconcia P; Bucci R; Corradi B; Farina M; Rizzo MA; Stucchi A
J Vasc Access; 2014; 15(6):461-5. PubMed ID: 24811590
[TBL] [Abstract][Full Text] [Related]
36. A six-year study of complications related to peripherally inserted central catheters: A multi-center retrospective cohort study in China.
Wan R; Gu L; Yin B; Cai S; Zhou R; Yang W
Perfusion; 2023 May; 38(4):689-697. PubMed ID: 35236188
[TBL] [Abstract][Full Text] [Related]
37. The safe implementation of peripherally inserted central catheters by nurse practitioners for patients with gastroenterological diseases in Japan: a single-center retrospective study.
Takematsu Y; Shibasaki S; Tanaka T; Hiro J; Takahara T; Matsuoka H; Uyama I; Suda K
Surg Today; 2024 May; 54(5):487-495. PubMed ID: 37731133
[TBL] [Abstract][Full Text] [Related]
38. Safety and Outcomes of Midline Catheters vs Peripherally Inserted Central Catheters for Patients With Short-term Indications: A Multicenter Study.
Swaminathan L; Flanders S; Horowitz J; Zhang Q; O'Malley M; Chopra V
JAMA Intern Med; 2022 Jan; 182(1):50-58. PubMed ID: 34842905
[TBL] [Abstract][Full Text] [Related]
39. A retrospective study of the safety of over 100,000 peripherally-inserted central catheters days for parenteral supportive treatments.
Campagna S; Gonella S; Berchialla P; Rigo C; Morano G; Zerla PA; Fuzzi R; Corona G; Storto S; Dimonte V; Mussa B
Res Nurs Health; 2019 Jun; 42(3):198-204. PubMed ID: 30912181
[TBL] [Abstract][Full Text] [Related]
40. Safe use of Peripherally Inserted Central Catheters for chemotherapy of solid malignancies in adult patients: A 1-year monocentric, prospectively-assessed, unselected cohort of 482 patients.
Piredda A; Radice D; Zencovich C; Cerri M; Aventino L; Naccarato F; Magon G; Biffi R
J Vasc Access; 2021 Nov; 22(6):873-881. PubMed ID: 33019880
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
